Individualized medicine can complement the principles of population health to deliver better results for patients, according to Leonard M. Fromer, MD, FAAFP, executive medical director of the Group Practice Forum.
Individualized medicine can complement the principles of population health to deliver better results for patients, according to Leonard M. Fromer, MD, FAAFP, executive medical director of the Group Practice Forum.
Transcript (slightly modified)
Can personalized medicine and the principles of population health be reconciled with one another, or are they at odds?
So here we are in the middle of a revolution in healthcare, moving from volume-based healthcare—how much care do we give?—to value-based care. No one’s waking up one morning and stepping right into value and leaving volume behind. So we really are moving from volume to volume plus value. And as we live in this volume plus value healthcare world, how do we reconcile the concepts of population health and dynamics disease state health and dynamics registries about accumulating data on the population we treat? And then, diving underneath that and saying, well, we have to reconcile that population analysis of the data with each individual person’s uniqueness and what do we do for that person within that population.
So are the two polar opposites or are they complementary? That’s the question. My belief is, and I think the data shows, that they complement each other. Because if we want to get the best Triple Aim results for patients, best outcomes, best experience in the care process, as they get those and we do it for lower cost in the population, deliver value. If we want to do that, it starts with, what does the science say around how patients need to be diagnosed and treated around a certain condition for instance. But also, what does the precision medicine initiative tell us about how we improve that population scorecard by getting great at what each individual unique patient needs for their own set of drivers, their own set of reasons why their body might need a different medication, or a different dose in a medication. Or of course also, approaching and doing something about their social dynamic and their social determinants.
IgE Mediation in Pediatric Atopic Dermatitis, Concurrent Immune Disorders: Amy Paller, MD
August 4th 2025Amy Paller, MD, pediatric dermatologist and clinical researcher at Northwestern Medicine's Feinberg School of Medicine, discussed the potential impact of reducing immunoglobulin E (IgE) levels in pediatric patients with atopic dermatitis.
Read More
Updated mRNA Vaccines Against JN.1 Show Strong Safety Signal in Real-World Data
July 31st 2025A nationwide Danish cohort study demonstrated no increased risk of serious adverse events following vaccination with JN.1-updated mRNA COVID-19 vaccines, reinforcing their safety profile and supporting continued use in high-risk populations amid ongoing viral evolution.
Read More
Proposed SNAP Cuts Could Threaten Prevention for Cognitive Decline, Dementias
July 30th 2025Supplemental Nutrition Assistance Program (SNAP) benefits may slow cognitive decline in older adults, highlighting the importance of food assistance in combating Alzheimer disease and dementia risks.
Read More